12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Beactica, J&J deal

Johnson & Johnson's Janssen Pharmaceutica N.V. unit and Beactica added the use of Beactica's Sprint surface plasmon resonance (SPR) to...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >